Ladenburg Thalmann Starts Viveve Medical (VIVE) at Buy, PT $22
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Ladenburg Thalmann initiated coverage on Viveve Medical (NASDAQ: VIVE) with a Buy rating and a price target of $22.00.
Shares of Viveve Medical closed at $7.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viveve Announces Additional Regulatory Approval in Southeast Asia
- Janney Montgomery Scott Starts FS Investment (FSIC) at Neutral
- Craig-Hallum Starts Douglas Dynamics (PLOW) at Buy
Create E-mail Alert Related CategoriesHot New Coverage, New Coverage
Related EntitiesLadenburg Thalmann Financial Services
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!